Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
Hirschorn
K A
KA
Department of Neurology, University of Michigan Hospitals, Ann Arbor 48109-0316.
Greenberg
H S
HS
D000368:Aged; D003533:Cyproheptadine / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008784:Methysergide / Q000627:therapeutic use; D009207:Myoclonus / Q000139:chemically induced / Q000188:drug therapy*; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy* / Q000209:etiology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000150:complications*
D003533:Cyproheptadine; D007980:Levodopa; D008784:Methysergide